| 发明名称 |
HUMAN MONOCLONAL ANTI-PD-L1 ANTIBODIES AND METHODS OF USE |
| 摘要 |
The present invention comprises human monoclonal antibodies that bind to PD-L1 (also known as programmed death ligand 1 or B7H1). Binding of the invented antibody to PD-L1 inhibits binding to its receptor, PD1 (programmed death 1), and ligand-mediated activities and can be used to treat cancer and chronic viral infections. |
| 申请公布号 |
EP2903641(A2) |
申请公布日期 |
2015.08.12 |
| 申请号 |
EP20130776696 |
申请日期 |
2013.10.04 |
| 申请人 |
DANA-FARBER CANCER INSTITUTE, INC. |
发明人 |
MARASCO, WAYNE, A.;SUI, JIANHUA |
| 分类号 |
A61K39/395;C07K16/28;C07K16/46 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
